← Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2023

Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis.

Mafalda Bacalhau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

60 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36986509